H
Henry G. Burger
Researcher at Prince Henry's Institute of Medical Research
Publications - 345
Citations - 22459
Henry G. Burger is an academic researcher from Prince Henry's Institute of Medical Research. The author has contributed to research in topics: Menopause & Follicle-stimulating hormone. The author has an hindex of 78, co-authored 345 publications receiving 21590 citations. Previous affiliations of Henry G. Burger include Walter and Eliza Hall Institute of Medical Research & Royal Children's Hospital.
Papers
More filters
Journal ArticleDOI
Updated practical recommendations for hormone replacement therapy in the peri- and postmenopause.
Martin Birkhäuser,Nick Panay,David F. Archer,David H. Barlow,Henry G. Burger,Marco Gambacciani,Steven R. Goldstein,J A Pinkerton,DW Sturdee +8 more
TL;DR: This book aims to provide a history of skateboarding in Europe from 1989 to 2002, with a focus on the period between 1991 and 2002.
Journal ArticleDOI
Elevated Serum Inhibin Concentrations in Postmenopausal Women With Ovarian Tumors
David L. Healy,Henry G. Burger,Pamela Mamers,Tom Jobling,Mohan Bangah,Michael A. Quinn,Peter Grant,Arthur J. Day,Robert M. Rome,James Campbell +9 more
TL;DR: Serum inhibin concentrations are elevated in most postmenopausal women with mucinous carcinomas of the ovary and in some women with other types of epithelial ovarian tumors, but the concentrations fall after tumor removal.
Journal ArticleDOI
Biological and immunological characterization of inhibin forms in human plasma.
David Robertson,Henry G. Burger,J Sullivan,N. Cahir,NP Groome,E Poncelet,P Franchimont,Teresa K. Woodruff,JP Mather +8 more
TL;DR: It is concluded that dimeric inhibin A specific assays detected bioactive inhibin forms in hFF and to a lesser extent in IVF serum, which suggested that there was little free alpha subunit.
Journal ArticleDOI
Estrogen receptor isoform gene expression in ovarian stromal and epithelial tumors.
TL;DR: The patterns of both ERalpha and ERbeta gene expression were defined in a panel of ovarian tumors consisting of GCT and serous and mucinous cystadenocarcinomas as well as in normal ovary to influence the response of a tumor to antiestrogen therapy.
Journal ArticleDOI
The treatment-seeking woman at menopause
Carol Morse,Anthony M.A. Smith,Lorraine Dennerstein,Adèle C. Green,John L. Hopper,Henry G. Burger +5 more
TL;DR: Findings show that treatment utilisers, in contrast to non-utilisers, reported a wider range of general symptoms, but reports on vasomotor symptoms did not contribute to the regression analysis.